This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Celgene Corporation. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Mary Adams: Innovator in Combination Therapies
Introduction
Mary Adams is a notable inventor based in Mountain Lakes, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of combination therapies. Her work focuses on innovative methods to treat diseases responsive to specific inhibitors.
Latest Patents
Mary Adams holds 1 patent for her invention titled "Combination therapies comprising apremilast and Tyk2 inhibitors." This patent outlines methods for treating diseases and disorders that respond to the inhibition of PDE4. The invention involves administering apremilast alongside a Tyk2 inhibitor to a subject. Additionally, it includes pharmaceutical compositions that combine these two components.
Career Highlights
Mary is currently employed at Celgene Corporation, where she continues to advance her research and development efforts. Her work has the potential to impact the treatment landscape for various diseases, showcasing her dedication to innovation in the pharmaceutical industry.
Collaborations
Throughout her career, Mary has collaborated with esteemed colleagues such as Peter Henry Schafer and Lisa Beebe. These partnerships have contributed to her success and the advancement of her research initiatives.
Conclusion
Mary Adams exemplifies the spirit of innovation in the pharmaceutical field through her groundbreaking work on combination therapies. Her contributions are paving the way for new treatment options and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile